Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
DCGO Stock Summary
Top 10 Correlated ETFs
In the News
DocGo to Present at the Benchmark Company's Upcoming Discovery One-on-One Investor Conference
NEW YORK--( BUSINESS WIRE )--DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, President, will participate in Benchmark Company's 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1st, 2022 at the New York Athletic Club in New York City. Mr. Capone is scheduled to participate in one-on-one meetings with institutional analysts and investors throughout the day.
DocGo: Current Post-Earnings Sell-Off Presents Double-Digit Upside Potential
DocGo Q3 beat topline revenue but missed bottom-line earnings; however, that was due to accounting for a one-time loss from the remeasurement of warrant liabilities. The end of Covid Testing did not materially impact its revenue stream, while its long-term municipal contracts are looking to expand, serving as a recession cushion.
DocGo Announces Upcoming Participation in Four Investor Conferences
NEW YORK--(BUSINESS WIRE)--DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, President will participate at the following four investor conferences during the month of November: Citi Consumer Dirsputive Growth Conference on Monday, November 14 at 8:30AM Eastern Time.
DocGo Inc. (DCGO) Q3 2022 Earnings Call Transcript
DocGo Inc. (NASDAQ:DCGO ) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Mike Cole - Vice President, IR Stan Vashovsky - CEO, Co-Founder Andre Oberholzer - CFO Anthony Capone - President Conference Call Participants Matt Shae - Needham Sarah James - Barclays Richard Close - Canaccord Genuity Kieran Ryan - Deutsche Bank Mike Latimore - Northland Securities David Grossman - Stifel Operator Thank you for standing by. This is the conference operator.
DocGo to Announce Third Quarter 2022 Results on Monday, November 7
NEW YORK--(BUSINESS WIRE)--DocGo (Nasdaq: DCGO) will report results for the third quarter ended September 30, 2022, after the markets close on Monday, November 7.
DocGo Announces Upcoming Participation at LD Micro Investor Conference
NEW YORK--(BUSINESS WIRE)--DocGo's Vice President of Investor Relations, Michael Cole, to participate at LD Micro's The Main Event investor conference 10/25 at 11:00 AM ET.
Is Motion Acquisition (DCGO) Outperforming Other Medical Stocks This Year?
Here is how DocGo Inc. (DCGO) and Shockwave Medical (SWAV) have performed compared to their sector so far this year.
3 IPO Stocks That You Want to Own
This down market is giving us some really intriguing stocks at cheap prices.
This Company Could Beat Out Teladoc, and It's Not Amazon
A potentially disruptive business model is finding its legs in the post-pandemic healthcare landscape.
DocGo: A Tech Story Wrapped In Telehealth And Last-Mile Care
Headquartered in NYC, DocGo provides innovative solutions to urban healthcare problems. The company has had a strong growth momentum since its IPO and is in a healthy financial condition.
DCGO Financial details
DCGO Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
|Revenue per share||0.94||3.97|
|Net income per share||-0.14||0.3|
|Operating cash flow per share||-0.11||-0.02|
|Free cash flow per share||-0.17||-0.11|
|Cash per share||0.32||2.19|
|Book value per share||0.55||2.73|
|Tangible book value per share||0.5||2.59|
|Share holders equity per share||0.55||2.73|
|Interest debt per share||0.14||0.2|
|Price to sales ratio||10.82||1.63|
|EV to sales||10.63||1.13|
|Enterprise value over EBITDA||-112.46||11.78|
|EV to operating cash flow||-93.83||-185.52|
|EV to free cash flow||-58.91||-41.74|
|Free cash flow yield||-0.02||-0.02|
|Debt to equity||0.18||0.05|
|Debt to assets||0.33||0.27|
|Net debt to EBITDA||2.08||-5.19|
|Sales general and administrative to revenue||0.41||0.25|
|Research and developement to revenue||0.01||0.01|
|Intangibles to total assets||0.17||0.06|
|Capex to operating cash flow||0.59||3.44|
|Capex to revenue||-0.07||-0.02|
|Capex to depreciation||-1.15||-0.95|
|Stock based compensation to revenue||0.01||0|
|Return on tangible assets||-0.17||0.08|
|Tangible asset value||49.66M||207.69M|
|Net current asset value||25.2M||173.49M|
|Days sales outstanding||96.42||89.77|
|Days payables outstanding||23||27.66|
|Days of inventory on hand||0||0|
|Capex per share||-0.06||-0.08|
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
|Revenue per share||0.86||1.21||1.18||1.1||1.05|
|Net income per share||0.03||0.24||0.11||0.13||0.03|
|Operating cash flow per share||0.08||-0.09||0.18||0.12||0.07|
|Free cash flow per share||0.07||-0.11||0.17||0.11||0.05|
|Cash per share||0.39||1.75||1.88||2||1.71|
|Book value per share||0.56||2.19||2.32||2.49||2.67|
|Tangible book value per share||0.5||2.07||2.21||2.37||2.18|
|Share holders equity per share||0.56||2.19||2.32||2.49||2.67|
|Interest debt per share||0.23||0.16||0.16||0.15||0.21|
|Price to sales ratio||11.63||7.72||7.86||6.47||9.41|
|EV to sales||11.44||6.41||6.4||4.8||7.98|
|Enterprise value over EBITDA||167.13||31.3||57.47||34.59||92.48|
|EV to operating cash flow||122.78||-88.41||41.33||44.08||112.21|
|EV to free cash flow||136.27||-70.02||44.08||47.34||153.4|
|Free cash flow yield||0.01||-0.01||0.02||0.02||0.01|
|Debt to equity||0.18||0.05||0.04||0.04||0.05|
|Debt to assets||0.53||0.27||0.26||0.23||0.24|
|Net debt to EBITDA||-2.75||-6.4||-13.07||-12.08||-16.55|
|Sales general and administrative to revenue||0.24||0.24||0.21||0.25||0.23|
|Research and developement to revenue||0.01||0.01||0.01||0.01||0.01|
|Intangibles to total assets||0.12||0.06||0.06||0.06||0.16|
|Capex to operating cash flow||-0.1||0.26||-0.06||-0.07||-0.27|
|Capex to revenue||-0.01||-0.02||-0.01||-0.01||-0.02|
|Capex to depreciation||-0.39||-1.48||-0.52||-0.4||-0.66|
|Stock based compensation to revenue||0.01||0||0.01||0.02||0.01|
|Return on tangible assets||0.03||0.08||0.03||0.04||0.01|
|Tangible asset value||49.63M||207.69M||221M||235.29M||215.65M|
|Net current asset value||19.71M||173.49M||183.24M||198.22M||166.91M|
|Days sales outstanding||53.99||58.15||58.15||59.38||69.02|
|Days payables outstanding||20.06||19.82||17.45||16.56||15.35|
|Days of inventory on hand||0||0||0||0||0|
|Capex per share||-0.01||-0.02||-0.01||-0.01||-0.02|
DCGO Frequently Asked Questions
What is DocGo Inc. stock symbol ?
DocGo Inc. is a US stock , located in New york of Ny and trading under the symbol DCGO
Is DocGo Inc. buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $11. The lowest prediction is $11 and the highest is $11
What is DCGO stock prediction ?
What is DocGo Inc. stock quote today ?
DocGo Inc. stock price is $6.65 today.
Is DocGo Inc. stock public?
Yes, DocGo Inc. is a publicly traded company.